Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 3.89
-9.53 %
$ 275 M
Market Cap
-2.25
P/E
CASH FLOW STATEMENT
-56.3 M
OPERATING CASH FLOW
13.1 M
INVESTING CASH FLOW
11 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Personalis, Inc.
| Net Income | -108 M |
| Depreciation & Amortization | 11.3 M |
| Capital Expenditures | -10.9 M |
| Stock-Based Compensation | 14.1 M |
| Change in Working Capital | 13.5 M |
| Others | 24.5 M |
| Free Cash Flow | -67.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (108.3) | (113.3) | (65.2) | (41.3) | (25.1) | (19.9) | (23.6) |
| Depreciation & Amortization | 11.3 | 8.4 | 6.0 | 5.8 | 4.7 | 3.1 | 1.2 |
| Deferred Income Tax | 0 | 0 | 2.0 | 0.4 | 3.1 | 4.5 | 0.2 |
| Stock Based Compensation | 14.1 | 19.4 | 14.4 | 8.2 | 4.9 | 1.3 | 0.8 |
| Other Operating Activities | 13.2 | 4.6 | 3.1 | 1.5 | 1.6 | 1.2 | 0.9 |
| Change in Working Capital | 13.5 | 10.6 | (31.1) | (17.2) | (7.3) | 15.4 | 20.8 |
| Cash From Operations | (56.3) | (70.2) | (70.8) | (42.7) | (18.1) | 5.6 | 0.3 |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | (10.9) | (49.9) | (11.1) | (3.2) | (8.4) | (7.9) | (5.2) |
| Other Items | 24.0 | 102.4 | (49.0) | (61.9) | (73.2) | 0 | 0 |
| Cash From Investing Activities | 13.1 | 52.5 | (60.1) | (65.1) | (81.6) | (7.9) | (5.2) |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0.2 | (1.1) | 3.3 | 0 | (5.0) | (0.6) | 16.4 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.3 | 2.5 | 4.1 | 3.8 | (4.1) | 54 K | 2 K |
| Cash From Financing Activities | 11.0 | 1.4 | 169.7 | 121.3 | 134.9 | (0.6) | 16.4 |
| CHANGE IN CASH | |||||||
| Net Change In Cash | (32.1) | (16.5) | 38.9 | 13.5 | 35.3 | (2.9) | 11.5 |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (67.2) | (120.1) | (81.9) | (45.9) | (26.5) | (2.3) | (4.9) |